StockData

ICON vs Iqvia

ICLR and IQV side by side, both in engineering, accounting, research, management, and related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ICLR and IQV compare

Iqvia grew revenue faster over the last twelve months (8.2% versus 1.7% for ICON).

Iqvia keeps more of each dollar of sales as profit, with a net margin of 8.1% compared with 0.51% at ICON.

Iqvia scores higher on the StockData Score (8 against 4 for ICON), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricICLRIQV
Size and price
Market cap–$44.0B
Share price$211.36$267.33
Change, 1 year27.4%22.7%
Change, 5 years−20.5%8.1%
Beta (5Y)1.241.17
Employees40K93K
StockData Score
Total score48 (better)
Valuation score00
Growth score04 (better)
Performance score24 (better)
Health score2 (better)0
Dividend score00
Valuation
P/E–33.2×
P/S–2.6×
P/B–7.1×
EV/EBITDA–17.2×
P/FCF–20.1×
PEG–2.99
FCF yield–5.0%
Fair value–$222.72
Margin of safety–−20.0%
Growth
Revenue growth (TTM)1.7%8.2% (better)
Revenue growth, 5Y average24.2% (better)7.5%
Net income growth (TTM)−95.1%11.2% (better)
EPS growth (TTM)−94.8%16.6% (better)
EPS growth, 5Y average−14.0%40.5% (better)
Profitability
Gross margin23.9%33.0% (better)
Operating margin3.6%13.0% (better)
Net margin0.51%8.1% (better)
FCF margin10.7%12.9% (better)
Return on equity0.45%23.0% (better)
Return on invested capital2.0%9.4% (better)
Financial health
Debt / equity0.23 (better)2.59
Net debt / EBITDA1.77 (better)4.11
Interest coverage1.5×2.9× (better)
Current ratio0.95 (better)0.71
Altman Z-score–2.20
Piotroski F-score66
Dividends and buybacks
Buyback yield–2.6%
Shareholder yield–2.6%
Ownership
Held by institutions105%95.3%
Held by insiders0.57%1.1%
Insider net buying, 12 months−$4.0M (better)−$38.0M
Superinvestors holding4 (better)3
Short interest, % of float3.7%2.0%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.